추가 설명:
Axitinib (CAS 319460-85-0) is a pharmaceutical-grade active ingredient manufactured directly by the supplier to in-house standards, indicated for adult patients with advanced renal cell carcinoma who have previously received a tyrosine kinase inhibitor or failed cytokine therapy. It is distributed across North America, Central/South America, Europe, Australasia, Asia, the Middle East and Africa.
평가 & 댓글 남기기